Ramucirumab for advanced hepatocellular carcinoma in the current real world: a Japanese single-arm study post-REACH-2 (The R-evolution study)

  • Kazufumi Kobayashi
  • , Sadahisa Ogasawara
  • , Ei Itobayashi
  • , Tomomi Okubo
  • , Norio Itokawa
  • , Kazuyoshi Nakamura
  • , Michihisa Moriguchi
  • , Shunji Watanabe
  • , Masafumi Ikeda
  • , Hidekatsu Kuroda
  • , Tomokazu Kawaoka
  • , Atsushi Hiraoka
  • , Yutaka Yasui
  • , Teiji Kuzuya
  • , Rui Sato
  • , Hiroaki Kanzaki
  • , Keisuke Koroki
  • , Masanori Inoue
  • , Masato Nakamura
  • , Soichiro Kiyono
    • Naoya Kanogawa, Takayuki Kondo, Shingo Nakamoto, Yoshihito Ozawa, Kaoru Tsuchiya, Masanori Atsukawa, Hiroshi Aikata, Takeshi Aramaki, Shiro Oka, Naoki Morimoto, Masayuki Kurosaki, Yoshito Itoh, Namiki Izumi, Naoya Kato

研究成果: ジャーナルへの寄稿 › 学術論文 › 査読

フィンガープリント

「Ramucirumab for advanced hepatocellular carcinoma in the current real world: a Japanese single-arm study post-REACH-2 (The R-evolution study)」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science